¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"professional activity study"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
insulin-like activity
Àν¶¸°À¯»çȰ¼ºµµ
integrated neural activity
ÅëÇսŰæÈ°¼º
molar activity
¸ôȰ¼º
mental activity
Á¤½ÅȰµ¿
psychomotor activity
Á¤½Å¿îµ¿È°µ¿
partial agonistic activity
ºÎºÐÀÛ¿ëÁ¦È°¼º
specific activity
1. ºñ¹æ»ç´É 2. ºñ(Ýï)Ȱ¼ºµµ, °íÀ¯È°¼ºµµ
spontaneous activity
ÀÚ¹ßÀüÀ§
structure activity relationship
±¸Á¶È°¼º»ó°ü°ü°è, ±¸Á¶ÀÛ¿ë°ü°è
sexual activity
¼ºÈ°µ¿
air study
°ø±âÁÖÀÔ°Ë»ç
cohort study
ÄÚȣƮ¿¬±¸, ÄÚȣƮÁ¶»ç
controlled clinical study
°ü¸®ÈÀÓ»ó½ÃÇè
crossover study
±³Â÷¿¬±¸
cross-sectional study
´Ü¸é¿¬±¸
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
6
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
prospective study
ÀüÇ⿬±¸, °èȹ¿¬±¸, ¾Õ¹æÇ⿬±¸, Àü¸Á¿¬±¸
prospective cohort study
ÀüÇâÄÚȣƮ¿¬±¸
retrospective study
ÈÄÇ⿬±¸, µÞ¹æÇ⿬±¸, ȸ°í¿¬±¸
retrospective cohort study
ÈÄÇâÄÚȣƮ¿¬±¸
single blinding study
´Ü¼ø¸Í°Ë¹ý
urodynamic study
¿ä¿ªµ¿Çа˻ç
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
integrated neural activity
ÅëÇսŰæÈ°¼º
involuntary activity
ºÒ¼öÀÇȰµ¿
mental activity
Á¤½ÅȰµ¿
molar activity
¸ôȰ¼º
partial agonistic activity
ºÎºÐÈ¿´ÉȰ¼º
psychomotor activity
Á¤½Å¿îµ¿È°µ¿
reflex gamma activity
¹Ý»ç°¨¸¶È°µ¿
sexual activity
¼ºÈ°µ¿
specific activity
ºñ¹æ»ç´É, ƯÀÌȰ¼ºµµ
spontaneous activity
ÀÚ¹ßÀüÀ§
time-activity curve
½Ã°£¹æ»ç´É°î¼±
structure activity relationship
±¸Á¶È°¼º»ó°ü°ü°è, ±¸Á¶ÀÛ¿ë°ü°è
sperm activity grade test
Á¤Àڿµî±Þ°Ë»ç
air study
°ø±âÁÖÀÔ°Ë»ç
arterial blood gas study
µ¿¸ÆÇ÷°¡½ººÐ¼®
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
pressure-perfusion study
¾Ð·Â°ü·ù°Ë»ç
prospective study
°èȹÀû¿¬±¸, ÀüÇâÀû¿¬±¸
real time study
½Ç½Ã°£ °Ë»ç
SAR : structure activity relationship
±¸Á¶ÀÛ¿ë°ü°è.
activity
Ȱ¼ºµµ(üÀàõöô), Ȱµ¿µµ(üÀÔÑöô), Ȱ¼º(üÀàõ).
activity
¹æ»ç´É, Ȱ¼ºµµ
activity therapist
Ȱµ¿ ¿ä¹ý»ç
activity therapy
Ȱµ¿¿ä¹ý(¡èþÛö).
activity therapy
Ȱµ¿ ¿ä¹ý
activity, antibacterial
Ç×±ÕÀÛ¿ë
amylase activity
¾Æ¹Ð¶óÁ¦-Ȱ¼ºµµ
antibacterial activity
Ç×±ÕÀÛ¿ë(ù÷жíÂéÄ), Ç×±ÕȰ¼º(ù÷жüÀàõ).
functional activity
±â´É¼º Ȱ¼ºµµ<Ȱµ¿µµ>
fusion activity
À¶ÇÕ´É
glucagon activity
±Û·çÄ«°ïȰ¼ºµµ.
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
double-blind study
ÀÌÁ߸ͰË.
family study
°¡Á·Á¶»ç(¿¬±¸)
first pass study
ÀÏÂ÷Åë°ú°Ë»ç.
follow-up study
ÃßÀûÁ¶»ç
infection control study
°¨¿°°ü¸®¿¬±¸
microbiologic study
¹Ì»ý¹°ÇÐÀû °Ë»ç
molecular genetic study
ºÐÀÚÀ¯ÀüÇÐ<ÀÚ>°Ë»ç
nested case control study
phase 1 study
ÀÓ»óÁ¦1»ó½ÃÇè.
pilot study
¿¹ºñ½ÇÇè.
population study
Àα¸Á¶»ç
preclinical study
ÀüÀÓ»ó½ÃÇè(îñìúßÉãËúÐ).
pressure flow study
¾Ð·ù·® Á¶»ç
pressure-perfusion study
¾Ð·Â°ü·ù°Ë»ç
prospective study
°èȹÀû¿¬±¸, ÀüÇâÀû¿¬±¸
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½